Summary
Research Technician producing recombinant antibodies and viral spike proteins for viral vaccine optimisation and using cutting-edge techniques to analyse samples from viral vaccine trials.
Extensive laboratory experience in virus and translational research in both academia and industry. Highly experienced in laboratory techniques including protein science, molecular biology and mammalian cell culture plus a wide range of cell-based and biochemical assays in GLP and vaccine/drug development contexts.
Publications
Journals
Shattock RJ, Andrianaivoarimanana V, Mckay PF, et al., 2023, A self-amplifying RNA vaccine provides protection in a murine model of bubonic plague, Frontiers in Microbiology, Vol:14
Blakney AK, McKay PF, Hu K, et al., 2021, Polymeric and lipid nanoparticles for delivery of self-amplifying RNA vaccines, Journal of Controlled Release, Vol:338, ISSN:0168-3659, Pages:201-210
Herrera C, Harman S, Aldon Y, et al., 2021, The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate, Aids, Vol:35, ISSN:0269-9370, Pages:1907-1917
McKay PF, Hu K, Blakney AK, et al., 2020, Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice, Nature Communications, Vol:11, ISSN:2041-1723, Pages:1-7
Aldon Y, McKay PF, Allen J, et al., 2018, Rational design of DNA-expressed stabilized native-like HIV-1 envelope trimers, Cell Reports, Vol:24, ISSN:2211-1247, Pages:3324-3338.e5